TERUFLEX® BLOOD BAG SYSTEM WITH DIVERSION BLOOD SAMPLING ARM® CPD/OPTISOL® SOLUTION

Manufacturer
Terumo Corporation | Terumo Corp. - Fujinomiya Factory
Effective date
2018-12-06
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-05-31 20:30:42

Label at a glance#

ProductTERUFLEX Blood Bag System with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISO...
Active ingredientTrisodium Citrate Dihydrate, SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM, Dextrose Monohydrate, Anhydrous Citric Acid, Sodium Chloride, Mannitol, Adenine
Label structure2 sections

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

Issued 6/03


TERUFLEX® BLOOD BAG SYSTEM With DIVERSION BLOOD SAMPLING ARM® CPD/OPTISOL® SOLUTION

Read these instructions carefully before use. Rx ONLY.
The Diversion Blood Sampling Arm™ is intended to divert and collect blood for obtaining donor test samples.

• For single use only. Sterile and non-pyrogenic fluid path. Sterilized by steam.
• Intended for the collection, processing and preservation of human blood and components.

PRECAUTIONS
• Do not use unless the solutions are clear.
• Avoid excessive heat and direct sunlight. Protect from freezing.
• Recommended storage conditions: Room Temperature (15-30°C/59-86°F).
• The blood bag configuration is specified on the blister pack label.

CAUTION Do not use a dielectric tube sealer to seal the tubing while the needle is connected to the donor's body unless it is approved for such a purpose.

INSTRUCTIONS FOR BLOOD COLLECTION: Use aseptic technique

Materials Needed:
VENOJECT® ll Tube Holder (code P-1316R) or equivalent
VENOJECT® ll Multi-Sample Luer Adapter (code MN *2000T) or equivalent
Evacuated Blood Collection Tubes (glass or plastic)

1. Prepare the blood bag following your institution's standard operating procedures.
2. If applicable, make a loose knot in the donor tubing below the "Y" and CLIKTIP™ (inline closure device) unless alternate methods are used to seal the tubing at the end of collection.
3. Temporarily clamp the donor tubing between the phlebotomy needle and the "Y".
4. Close the White Clamp below the diversion pouch.
5. Tube Holder/Luer Adapter Assembly:
a) Connect the VENOJECT II Multi-Sample Luer Adapter to the VENOJECT II Tube Holder (or equivalent) (Fig.1).

Insert Fig. 1 here

Image Fig. 1 (attach luer adapter to tube holder)
Image Fig. 1 (attach luer adapter to tube holder)



b) Twist and snap to remove the blue port cap at the end of the Diversion Blood sampling Arm (Fig. 2a).
c) Connect the multi-sample luer adapter to the female luer port. (Fig. 2b)
NOTE: Alternatively, steps a, b and c (above) may be performed at any time during bag preparation or after the blood is collected into the diversion pouch.

Insert Fig. 2a and 2b here

Image of Fig. 2a and Fig. 2b (DBSA)
Image of Fig. 2a and Fig. 2b (DBSA)



6. Suspend the collection bag as far as possible below the donor's arm.
7. Apply blood pressure cuff or tourniquet to donor's arm. Disinfect site of phlebotomy. If blood pressure cuff is used, inflate to approximately 60 mmHg.
8. Remove the needle cover and perform phlebotomy. Remove the temporary clamp on the donor tubing to permit blood flow into the Diversion Blood Sampling Arm pouch.
CAUTION Do not touch the needle after removing the needle protector. Assure that the White Clamp below the pouch is closed prior to initiating phlebotomy.
9. If using a needle safety device, follow the manufacturer's instructions to secure the device in place.
10. Appropriately secure donor tubing to donor's arm.
11. Position the diversion pouch with the notches up and the Tube Holder/Luer Adapter assembly (or port cap) down. When the level of blood in the pouch is approximately in line
with the notches, the diversion pouch is full. (Fig. 3a)
NOTE: The approximate fill volume of the pouch at the notches is 35 mL.
12. Permanently seal the tubing between the "Y" and the diversion pouch to maintain a closed system using an aluminum clip or a tube sealer approved for use with tubing connected to a donor. (Fig. 3b)
13. To initiate blood flow into the collection bag, break the CLlKTIP between the "Y" and the primary bag.
14. To avoid clot formation, collect samples as soon as possible from the diversion pouch as follows (Fig. 3b)
CAUTION Do not collect donor test samples until the tubing between the "Y" and the diversion pouch is permanently sealed.
a) Open the White Clamp on the tubing below the pouch to open the pathway for sampling.
b) Position the diversion pouch with the notches up and the Tube Holder/Luer Adapter assembly down. Assure that any air in the pouch is at the top and will not enter the
blood collection tubes.
c) Insert vacuum blood collection tube firmly into the tube holder; when full, remove sample tube from holder. Repeat to collect additional samples.
NOTE: The pouch may be removed after the donor test samples are collected. A second seal must be made between the diversion pouch and the permanent seal
prior to removing the pouch.

Insert Fig. 3a and 3b here

Image of Fig. 3a and Fig. 3b (filling DBSA)
Image of Fig. 3a and Fig. 3b (filling DBSA)



15. Once samples are obtained, mix blood with anticoagulant in the primary bag and continue to mix at several intervals during collection.
16. Collect labeled volume of blood (+/–10%).
17. When the desired amount of blood has been collected, seal the tubing or tighten the loose knot (white knot) prepared in step 2. Make a second seal between the first seal or knot and
the CLlKTIP below the "Y". Various methods may be used to seal tubing.
18. Release pressure on the donor's arm and remove the needle. If using a needle safety device, follow the manufacturer's instructions to remove the needle. Sever the donor tubing between the two seals previously made below the CLlKTIP and "Y".
CAUTION Discard the Diversion Blood Sampling Arm and phlebotomy needle/donor tubing according to institutional procedures.
19. Immediately after collection, invert the bag several times to assure blood and anticoagulant are well mixed.
20. Strip blood from the donor tubing into the bag, mix well, and allow tubing to refill. Seal on or near the X marks on the donor tubing to provide numbered aliquots of anticoagulated blood for testing.
21. The time of addition of OPTISOL Solution may vary depending on the processing option selected. Add the solution under one of the following conditions after removal of plasma:
a) Within 8 hours of whole blood collection, if components are prepared.
b) Within 72 hours of collection if whole blood is refrigerated immediately following collection.
22. Centrifuge the unit to separate red cells from plasma.
23. Break the CLlKTIP of primary collection bag and transfer the plasma into the satellite bag. Clamp transfer tubing of satellite bag.
24. Break the CLlKTIP of OPTlSOL Solution bag and drain contents into primary bag containing red blood cells. Seal tubing of primary bag in two places, and cut between seals
and separate from satellite bag(s).
NOTE: For TERUFLEX double bags, seal OPTISOL Solution bag tubing in two places and cut between seals. Discard OPTISOL Solution container.
25. Invert the red cell- OPTISOL mixture several times to insure the final AS-5 red cell product is well suspended.
26. Store AS-5 Red Blood Cells between 1-6°C.
27. Infuse AS-5 Red Blood Cells within 42 days of collection.

For further processing, use standard component processing techniques.

To open blister package, peel cover film back four fifths of its length.

After opening, unused bags may be stored for 30 days by returning cover film to original position and sealing with tape to prevent possible loss of moisture.

Insert Fig. 4 here

Image Figure Sealing with tape
Image Figure Sealing with tape



CAUTIONS
•The packet of AGELESS contained in this package absorbs oxygen and generates heat on removal. Handle it with care.
• Dispose with packet in tray.
• Do not dispose with wastes containing volatile or flammable materials.
• Discard AGELESS packet without opening.

N-BB-OP-A2(DB) 1

TERUMO® MANUFACTURED BY: TERUMO CORPORATION 44-1, 2-CHOME, HATAGAYA, SHIBUYA-KU, TOKYO, JAPAN MADE IN JAPAN
®: Registered Trademark Diversion Blood Sampling Arm and CLIKTIP are trademarks of TERUMO CORPORATION.
© TERUMO CORPORATION 2003 03F10

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL


Tray/Case Label

TERUFLEX® BLOOD BAG SYSTEM with
DIVERSION BLOOD SAMPLING ARM®


CPD WITH OPTISOL® RED CELL PRESERVATIVE SOLUTION
FOR COLLECTION OF 450mL OF BLOOD


Each unit consists of a collection bag containing 63mL of Anticoagulant
CPD solution, with a satellite bag containing 100mL of OPTlSOL Red
Cell Preservative Solution.
Each 63mL Anticoagulant CPD solution USP contains 1.61g Dextrose
(monohydrate) USP, 1.66g Sodium Citrate (dihydrate) USP, 188mg Citric
Acid (anhydrous) USP, 140mg Monobasic Sodium Phosphate
(monohydrate) USP.
Each 100mL OPTISOL Red Cell Preservative Solution contains 877mg
Sodium Chloride USP, 900mg Dextrose (monohydrate) USP, 525mg
Mannitol USP, 30mg Adenine USP.
STERILE, NON-PYROGENIC FLUID PATH.
DO NOT USE UNLESS ANTICOAGULANT IS CLEAR.


CODE

LOT No.

EXPIRY

UNITS

DONOR NEEDLE 16G x 1 1/2˝ (1.60 x 38mm)

Rx ONLY

RECOMMENDED STORAGE: Room Temperature (15-30°C/59-86°F).
Avoid excessive heat. Protect from freezing.

After opening, unused bags may be stored for 30 days by returning cover film to original
position and sealing with tape to prevent possible loss of moisture.
See Instructions For Blood Collection.

Manufactured by : TERUMO CORPORATION Tokyo, Japan
® : Registered Trademark
Diversion Blood Sampling Arm is a trademark of TERUMO CORPORATION.

Issued 05/03
B-4-G6-A2 1
Place Label here

Image of Representative Tray/Case Label CPD-OPT 450mL with DBSA
Image of Representative Tray/Case Label CPD-OPT 450mL with DBSA



DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ANHYDROUS CITRIC ACID Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813
MANNITOL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
SODIUM CATION Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
95250459-30e4-45c1-b08a-993044f49109Product name220250805
efd58dcf-540a-4531-8766-e713129ca6f2Product name120250307
4b7700e3-6e0e-45e5-9d22-6f754d61386eProduct name220250304
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
a21a21e5-f36d-4c1f-8918-def921b8f7e3Product name320250124
fb7ab793-2c12-4079-b100-a64f73bef25aProduct name420240712
b0cbf770-6cc3-4aa4-9158-755110c2b9f7Product name220230717
cb89b86a-369e-4204-8910-ae797c503af3Product name120230706
dc7c5daa-021f-40dd-b00d-63982cb2067aProduct name120230426
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
9badc7be-250a-44ab-aa36-926af3f02679Product name120210527
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name520200925
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
d4880ace-a516-8c47-8dfd-73a4ba5887d7Product name220180830
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
26acd337-b838-40ac-bcbc-05c3b81c8712Product name120170323
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name220160823
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
53877-008-812025-01-30C16284748780-12cef2736-7d92-d83d-e063-dadaa90ab31fTERUFLEX® BLOOD BAG SYSTEM WITH DIVERSION BLOOD SAMPLING ARM® CPD/OPTISOL® SOLUTION

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
53877-008-81TERUFLEX Blood Bag System with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative1 in 1 BAGKIT14
53877-008-81TERUFLEX Blood Bag System with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative18 in 1 CASEKIT184

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
53877-008TERUFLEX BLOOD BAG SYSTEM WITH DIVERSION BLOOD SAMPLING ARM ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND OPTISOL (AS-5) RED CELL PRESERVATIVE (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND AS-5 RED CELL PRESERVATIVE) KIT [TERUMO CORPORATION]4Legacy NDC, 2 package rows20191217_f664b3fd-374c-4f04-abea-1a266dfea0e2.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
AdenineACTIVE INGREDIENTJAC85A21611
Anhydrous Citric AcidACTIVE INGREDIENTXF417D3PSL1
Dextrose MonohydrateACTIVE INGREDIENTLX22YL083G1
MannitolACTIVE INGREDIENT3OWL53L36A1
Sodium ChlorideACTIVE INGREDIENT451W47IQ8X1
Sodium Phosphate, MonobasicACTIVE INGREDIENT3980JIH2SW1
Trisodium Citrate DihydrateACTIVE INGREDIENTB22547B95K1
AdenineACTIVE MOIETYJAC85A21611
Citric AcidACTIVE MOIETY2968PHW8QP1
DextroseACTIVE MOIETYIY9XDZ35W21
MannitolACTIVE MOIETY3OWL53L36A1
Phosphoric AcidACTIVE MOIETYE4GA8884NN1
SODIUM CATIONACTIVE MOIETYLYR4M0NH371
WaterINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
53877-00853877-008-81

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
223f098a-ed15-410d-921e-c075c1330bd5f664b3fd-374c-4f04-abea-1a266dfea0e22018-12-06Exact identifier
spl id: 223f098a-ed15-410d-921e-c075c1330bd5
spl set id: f664b3fd-374c-4f04-abea-1a266dfea0e2

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.